CD25 antibodies
Synonyms: IL-2Rα, p55, Tac
Clone:
4E3
Type of antibody:
Primary antibodies
Isotype:
mouse IgG2b
Specifications for CD25 antibodies
Overview

4E3 recognizes the human CD25 antigen, a 55 kDa glycoprotein also known as the low-affinity interleukin-2 receptor alpha chain (IL-2Rα). CD25 is expressed on activated T and B cells, on macrophages, and on a subset of non-activated CD4+ regulatory T cells. The CD25 antigen contains three epitope regions called A, B, and C. This CD25 antibody recognizes epitope region B.

Alternative names

IL-2Rα, p55, Tac

Detailed product information

Technical specifications

Clone
4E3
Isotype
mouse IgG2b
Type of antibody
Primary antibodies
Species reactivity
human
Antigen
CD25
Molecular mass of antigen [kDa]
28
Distribution of antigen
B cells, macrophages, monocytes, NK cells, osteoblasts, T cells
Resources for CD25 antibodies
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for CD25 antibodies
Publications
  1. Wood, B. L. et al. (2007) 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin. Cytom. 72: 14-22
  2. Maloy, K. J. et al. (2001) Regulatory T cells in the control of immune pathology. Nat Immunol 2 (9): 816-822
  3. Shevach, E. M. (2001) Certified professionals: CD4+CD25+ suppressor T cells. J. Exp. Med. 193 (11): F41-F46
  4. Clinical and Laboratory Standards Institute (CLSI) (2007) Enumeration of immunologically defined cell populations by flow cytometry, CLSI document H42-A2 (ISBN 1-56238-640-9). CLSI Approved Guideline - Second Edition
  5. Lamprecht, B. et al. (2008) Aberrant expression of the Tʜ2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alpha. Blood 112 (8): 3339-3347
  6. Chaput, N. et al. (2013) Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR+ NK cell levels correlate with disease outcome. Oncoimmunology 2 (2): e23080
  7. Clinical and Laboratory Standards Institute (CLSI) (2007) Clinical Flow Cytometric Analysis of Neoplastic Hematolympoid Cells, CLSI document H43-A2 (ISBN 1-56238-635-2). CLSI Approved Guideline - Second Edition
  8. van Dongen, J. J. M. et al. (2012) EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 26 (9): 1908-1975
  9. Rothe, G et al. (2012) Consensus protocol for the flow cytometric Immunophenotyping of hematopoietic malignancies. Leukemia 10 (5): 877-895
  10. Stelzer, G. T. et al. (1997) U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry 30 (5): 214-230
  11. Knapp, W. et al. (eds) Leukocyte Typing IV. Oxford, Oxford University Press
  12. Sakaguchi, S. et al. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164